EmbryoTrans Biotech ApS: Financial statements 2016
CVR: 36701676
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,767,468 and a net result of DKK 132,445. Equity in the 2016 report amounted to DKK 454,997. The solvency ratio was 54.3%.
- Gross Profit
- DKK 1,767,468
- Profit/Loss
- DKK 132,445
- Equity
- DKK 454,997
- Total Assets
- DKK 838,133
Official annual report
Find more companies like EmbryoTrans Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
EmbryoTrans Biotech ApS has published its interim report for the period March 23, 2015 – December 31, 2015.
As of February 26, 2016, Lotte Bjørg Strøbech has joined the board of directors of EmbryoTrans Biotech ApS.
As of February 26, 2016, Ulrik Bangsbo Hansen is registered as chairman of EmbryoTrans Biotech ApS.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees (2018). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.